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Edited by Ulrike KutayAbstract In the present study, the nuclear delivery of a green
ﬂuorescence protein (GFP)-encoding pDNA condensed by prot-
amine was investigated in terms of trans-gene expression after
cytoplasmic (E(cyt)) and nuclear (E(nuc)) microinjection. To
compare the nuclear transfer process, a novel parameter; the nu-
clear transfer (NT) score was introduced. The E(cyt) value for
protamine/pDNA particles increased in a charge ratio-dependent
manner. The calculated NT score showed that this increase re-
sults from an enhancement in nuclear transfer eﬃciency, which
was also quantitatively conﬁrmed by a recently developed confo-
cal image-assisted three-dimensionally integrated quantiﬁcation
(CIDIQ) method. Moreover, E(nuc) for protamine/pDNA parti-
cles was signiﬁcantly higher than that for poly-L-lysine/pDNA
particles, suggesting that pDNA, when condensed with prot-
amine, is more accessible to intra-nuclear transcription. Collec-
tively, protamine is an excellent DNA condenser, with
bi-functional advantages: improvement in nuclear delivery and
eﬃcient intra-nuclear transcription.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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To develop a promising non-viral gene vector for clinical
applications, an improvement in transfection eﬃciency is
essential. Previous studies have clearly shown that various
intracellular barriers, such as lysosomal degradation and nu-
clear membrane limit trans-gene expression. Lysosomal degra-
dation can be avoided by utilizing various devices such as
pH-sensitive fusogenic lipids, consisting of the dioleoyl phos-
phatidylethanolamine (DOPE) and cholesteryl hemisuccinate
(CHEMS) [1–3], polycations that have proton sponge charac-
teristics [4,5], and pH-sensitive membrane lytic peptides [6–9].
However, the nuclear membrane continues to be a barrier to
transfection activity, especially in non-dividing cells. It has pre-
viously been reported that trans-gene expression is drastically
enhanced in the M-phase when the nuclear membrane struc-
ture is diminished [10–13]. Therefore, an eﬃcient system for*Corresponding author. Fax: +81 11 706 3733.
E-mail address: akita@pharm.hokudai.ac.jp (H. Akita).
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doi:10.1016/j.febslet.2005.02.071the nuclear delivery of plasmid DNA (pDNA) is highly desired
for the development of an artiﬁcial gene delivery system.
In an attempt to overcome the nuclear membrane barrier,
pDNA is typically condensed with a cationic nuclear targeting
signal peptide, such as cationic peptides modiﬁed with M9 de-
rived from heterogeneous nuclear ribonucleoprotein-A1 [14], a
TAT oligomer [15], a tetramer of the SV40 T-antigen-derived
nuclear localization signal (NLSSV40) [16], l [17–19], and
NLSSV40-l, a chimerical peptide of l and NLSSV40 (Akita
et al., submitted). In addition, protamine, a compound that
has been approved by the US FDA is widely used as a DNA
condenser ([20,21] and Moriguchi et al. submitted). As ﬁrst
proposed by Sorgi and collaborators [20], protamine has four
possible NLS-like regions consisting of basic amino acid and
proline or serine residues. The pre-condensation of pDNA
with protamine actually enhanced the trans-gene expression
mediated by cationic liposomes and/or polycations compared
with poly-L-lysine (PLL), a commonly used pDNA condenser.
However, based on these ﬁndings, it cannot be concluded that
protamine is a useful device for the nuclear delivery of pDNA,
since transfection activity is dependent on multiple intra-
cellular events, including cellular uptake, endosomal escape,
intracellular stability, nuclear transfer and intra-nuclear tran-
scription. Cytoplasmic and nuclear microinjection proven to
be a powerful technique for understanding the mechanism
from the point of view of nuclear transfer and intra-nuclear
transcription [22], since it enables the contribution of the eﬃ-
ciency of cellular uptake to be separated from and endosomal
escape.
In the present study, we report on a quantitative evaluation
of the nuclear transfer eﬃciency of protamine/pDNA particles
in terms of the trans-gene expression of green ﬂuorescence pro-
tein (GFP) after the cytoplasmic and nuclear microinjection of
GFP-encoding pDNA, compared to that of PLL/pDNA parti-
cles, to investigate the potential of the protamine as a nuclear
delivery device for pDNA.2. Material and methods
2.1. General
HeLa cells were obtained from the RIKEN Cell Bank (Tsukuba, Ja-
pan). To prepare the reporter gene vector for the pDNA, an insert
fragment encoding the EGFP was obtained by digesting EcoRI/NotI
digestion of pEGFP-N1 (Clontech, Palo Alto, CA, USA) with
EcoRI/NotI, followed by ligation to EcoRI/NotI digested site of
pcDNA3.1 (Invitrogen, Carlsbad, CA, USA). pDNA samples wereblished by Elsevier B.V. All rights reserved.
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sulfate was obtained from Calbiochem (Ishikari, Japan) in puriﬁed
form. Before use, protamine solution was ﬁltered through the cellulose
acetate ﬁlter (DISMIC-13cp: 0.2 lm pore size) obtained from Advan-
tech (Chiba, Japan). PLL (MW = 27400) was obtained from
Sigma–Aldrich (St. Louis, MO, USA). Tetramethylrhodamine-labeled
dextran (RhoDex: MW: 70000) was purchased from Molecular probe
(Eugene, OR, USA).2.2. Preparation of the polycation/pDNA complex
For the condensation of pDNA, 20 ll of a pDNA solution (0.1 lg/ll
in H2O) was added dropwise to 100 ll of polycation solution under
vortex for ﬁve times (totally 100 ll) at approximately 20-s intervals.
The concentration of the protamine and PLL (Cpolycation) at various
charge ratios (+/) was calculated using the following equation.
Charge ratio ¼ fCpolycation  ncation=MWpolycationg=ðCDNA=MWDNAÞ;
where ncation denotes the number of lysine and arginine residues in PLL
and protamine, respectively. MWpolycation and MWDNA denote the
molecular weight of the polycation (protamine: 4250, PLL: 27400)
and one nucleotide (average: 308), respectively. CDNA denotes the con-
centration of pDNA (0.1 lg/ll). As demonstrated previously, the poly-
cation/pDNA complex was readily aggregated when condensed under
a charge ratio of approximately 1.5 [23]. Therefore, charge ratio-
dependent trans-gene expression was analyzed at the charge ratio
above 2. The hydrodynamic diameter was measured by quasi-elastic
light scattering by means of an electrophoresis light scattering spectro-
photometer (ELS-8000, Otsuka electronics, Japan).
2.3. Microinjection study
The microinjection study was carried out, as described in the previ-
ous report [24] with minor modiﬁcations. Cells were seeded on the
glass base dish 1 day (IWAKI, Osaka, Japan) before the microinjec-
tion. In this procedure, a semiautomatic injection system (Eppendolf
transjector 5246, Hamburg, Germany) was attached to the Eppendolf
micromanipulator 5171. Cytoplasmic and nuclear microinjections were
performed under conditions of Pi = 50–70 hPa, Pc = 30 hPa and an
injection time of 0.2 s. Just prior to injection, the pDNA, condensed
with polycations, was diluted to 3.32 fmol/ll and 33.2 amol/ll with a
0.5% RhoDex/H2O solution for cytoplasmic or nuclear microinjection,
respectively. Under these conditions, 1000 copies and 10 copies of
pDNA, respectively, were injected. At 24 h post-injection, GFP-
expression was monitored by ﬂuorescence microscopy, and the ratio
of cells expressing GFP to RhoDex positive cells were calculated. In
the nuclear microinjection, the rhodamine-positive cells were counted
afterward, to avoid a situation in which the RhoDex diﬀuses into the
cytosol during the 24 h incubation, which would lead to an underesti-
mation of the number of nucleus-injected cells.Table 1
Physicochemical characteristics of polycation/pDNA particles
Sample name Charge
ratio
Size
(nm)
Zeta potential
(mV)
Protamine/pDNA 2.0 88.6 ± 9.0 8.9 ± 4.8
9.0 76.3 ± 8.5 17.7 ± 4.0
Poly-L-lysine/pDNA 2.0 71.2 ± 3.5 27.6 ± 6.1
9.0 65.7 ± 5.1 36.2 ± 9.3
Sizes and Z-potentials were measured an electrophoresis light scat-
tering spectrophotometer. Data are represented as means ± S.D. of
triplicate experiments.2.4. Quantitative evaluation of the nuclear delivery of protamine/pDNA
particle by confocal images
For visualization of the pDNA after cytoplasmic injection, pDNA
was labeled with rhodamine by the Label IT reagent (Panvera Corpo-
ration, Madison, WI, USA). At 1 h post-injection of the rhodamine-
labeled pDNA condensed with protamine at charge ratios of 2 and
9, cells were incubated with 0.5 lM SYTO24 for 15 min to stain the
nucleus. The cells were then washed three times with culture medium
including 10% fetal calf serum. Fluorescence and bright ﬁeld images
were captured using a Zeiss Axiovert 200 inverted ﬂuorescence micro-
scope equipped with Achroplan 63·/0.95N objective (Carl Zeiss Co.
Ltd.; Jena, Germany).
Quantiﬁcation of the confocal images to evaluate the nuclear trans-
fer eﬃciency was demonstrated by the recently developed confocal im-
age-assisted three-dimensionally integrated quantiﬁcation (CIDIQ)
method [25]. 20 Z-series images were obtained from the bottom of
the coverslip to the top of the cells and recorded by the Zeiss
LSM510 on a PC. Each 8-bit TIFF image was transferred to
Image-Pro Plus ver. 4.0 (Media Cybernetics Inc., Silver Spring, MD)
to quantify the total brightness and pixel area of each r.o.i.. For the
data analysis, the pixel areas of each cluster in the cytosol; si(cyt)
and nucleus si(nuc) were separately summed in each XY plane, and
are denoted as S 0Z¼jðcytÞ and S 0Z¼jðnucÞ, respectively. The values of
S 0Z¼jðcytÞ and S 0Z¼jðnucÞ in each X–Y plane were further summedthrough the all of Z-series of images, and are denoted as S(cyt) and
S(nuc), respectively. These values represent the total amount of pDNA
in the cytosol and the nucleus in an individual cell. The fractions of nu-
clear pDNA in the nucleus to the totally injected one; F(nuc), which
represents the nuclear transfer eﬃciency were calculated using the
equation below:
F ðnucÞ ¼ SðnucÞ
SðcytÞ þ SðnucÞ :3. Results
3.1. Physicochemical characterization of the polycation/pDNA
particles
The particle sizes and Z-potentials of the pDNA/polycation
particles condensed at charge ratios of 2 and 9 were character-
ized (Table 1). In the cases of both protamine and PLL, the
particle sizes were approximately 65–90 nm at both charge ra-
tios. The Z-potential of these particles increased depending on
the charge ratios. In addition, the Z-potentials of the PLL/
pDNA particles were signiﬁcantly higher than for the prot-
amine/pDNA particles.
3.2. Cytoplasmic and nuclear microinjections
We ﬁrst evaluated the percent of GFP-positive cells obtained
after cytoplasmic microinjection (E(cyt)). As shown in Fig.
1(a), the E(cyt) for protamine/pDNA particles at the high
charge ratio of 9 (41.8% ± 4.9) was signiﬁcantly higher than
that at the low charge ratio of 2 (16.1% ± 3.8). Between the
charge ratios of 2 and 9, E(cyt) was also increased in a charge
ratio dependent manner (24.7% ± 4.5 and 38.8% ± 4.6 at a
charge ratio of 4.5 and 6, respectively). At higher charge ratio
of 12, E(cyt) was lower (33.5% ± 3.9) than that at a charge ra-
tio of 9. In contrast, the E(cyt) values in PLL were not aﬀected
by the charge ratio (Fig. 1(a)). Therefore, the charge ratio-
dependent increase in E(cyt) was speciﬁc for protamine/pDNA
particles.
Since the maximum and minimum E(cyt) values occurred at
charge ratios of 9 and 2, respectively, the percent of GFP-
positive cells after nuclear microinjection (E(nuc)) were further
compared at these charge ratios, in order to compare the intra-
nuclear transcription eﬃciency. As shown in Fig. 1(b), the
E(nuc) values for both protamine and PLL were not aﬀected
by the charge ratio. It is noteworthy that the E(nuc) values
for the protamine/pDNA particles were higher than for PLL,
suggesting that pDNA, when condensed with protamine, is
more eﬃciently subject to the intra-nuclear transcription com-
pared with that condensed with PLL.
Fig. 1. GFP-expression after cytoplasmic and nuclear microinjection, and the calculated NT scores for protamine/pDNA particles and PLL/pDNA
particles. After cytoplasmic (a) and nuclear (b) microinjection of the pDNA condensed with protamine (closed bar) and PLL (open bar) at a charge
ratio of 2 and 9, 1000 copies of the pDNA, mixed with 0.5% RhoDex were injected to the cytoplasm of HeLa cells. At 24 h post-injection, the ratio of
GFP-positive cells to RhoDex-positive cells were calculated. Vertical bars indicate the standard deviation of triplicate experiments. NT scores (c)
were calculated as the percent of GFP-expression after cytoplasmic microinjection (E(cyt)) divided by that after nuclear microinjection (E(nuc)). The
statistical diﬀerences were determined by one-way ANOVA followed by Fishers PLSD test. P < 0.05.
T. Masuda et al. / FEBS Letters 579 (2005) 2143–2148 21453.3. Evaluation with a nuclear transfer score (NTscore)
The E(cyt) values were highly dependent on intra-nuclear
transcription eﬃciency as well as nuclear transfer eﬃciency.
In contrast, E(nuc) exclusively represents the eﬃciency of nu-
clear transcription. Therefore, we deﬁne a parameter of nucle-
ar transfer score (NT score), denoted as E(cyt) divided by
E(nuc) to compare the nuclear transfer process. The calculated
NT scores are summarized in Fig. 1(c). In protamine/pDNA
particles, the NT score signiﬁcantly increased depending on
the charge ratio, whereas it was unaﬀected in PLL/pDNA par-
ticles, indicating that the improvement in nuclear transfer eﬃ-
ciency is mainly due to the protamine/pDNA-speciﬁc increase
in E(cyt). Surprisingly, these scores indicate that the NT scores
of the protamine/pDNA particles and PLL/pDNA particles
are only a slightly diﬀerent from each other, which is inconsis-
tent with the general assumption that protamine is a more
proﬁtable polycation than PLL from the point of view of the
potential to deliver pDNA to the nucleus [20].
3.4. Quantitative evaluation of the nuclear delivery of
rhodamine-labeled pDNA with CIDIQ
The enhanced nuclear delivery of pDNA was further con-
ﬁrmed by the ﬂuorescence images captured by confocal laser
microscopy. Rhodamine-labeled pDNA was condensed with
protamine at charge ratios of 2 and 9 and injected to the cyto-Fig. 2. Intracellular distribution of rhodamine-labeled pDNA after the cy
protamine at a charge ratio of 2 (a) and 9 (b), were injected into the cytop
injection, the cells were incubated with 0.5 lM SYTO24 for 15 min to stain th
with protamine, were detected in both of the cytoplasm and nucleus (indicaplasm. At both charge ratios, pDNA signals were detected in
the cytoplasm and nucleus as a cluster (Fig. 2(a) and (b)). In
contrast, when naked DNA was injected, pDNA diﬀused
through the cytoplasm and was barely detected as a cluster
in the nucleus (Fig. 2(c)). These data suggest that pDNA, when
condensed with protamine, is able to translocate through the
nuclear membrane in a condensed form.
To conﬁrm the improvement in nuclear transfection eﬃ-
ciency, the confocal images were quantiﬁed by a recently devel-
oped CIDIQ method as mentioned in Section 2. As a result,
nuclear protamine/pDNA particles to the totally injected ones
(F(nuc)) at a charge ratio of 9 were higher than at a charge ra-
tio of 2 (Fig. 3), which is in agreement with the NT scores
shown in Fig. 1(c).4. Discussion
The nuclear membrane is a strict intracellular barrier, which
prevents eﬀective gene transfection. Since Sorgi et al. [20] ﬁrst
reported that the pre-condensation of pDNA with protamine
enhanced the transfection activity by lipoplex to a greater ex-
tent than PLL, many investigators recognize protamine as a
nuclear-targeting pDNA condenser based on the NLS-like
amino acid sequence. However, the condensation of pDNAtoplasmic microinjection. Rhodamine-labeled pDNA condensed with
lasm. As a control, naked pDNA were also injected (c). At 1 h post-
e nucleus. Dots, corresponding to rhodamine-labeled pDNA condensed
ted by arrows) as dot shapes.
Fig. 3. Quantitative evaluation of nuclear transfer eﬃciency based on
confocal images. The nuclear fractions of protamine/pDNA particles
condensed at charge ratios of 2 and 9 relative to the total amounts
injected were quantiﬁed by CIDIQ, as described in Section 2. 12
individual cells were analyzed in each group. \\ indicate signiﬁcant
diﬀerences determined by the Mann–Whitney test (P < 0.05).
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stability of the pDNA. Therefore, an evaluation of transfection
activity is not suﬃcient to conclude that protamine is potent in
delivering pDNA to the nucleus.
In the present study, we investigated the utility of the prot-
amine as a nuclear-targeting device by microinjection, in an at-
tempt to evaluate the nuclear transfer and intra-nuclear
transcription process [22]. In the case of cytoplasmic microin-
jection, the E(cyt) of protamine/pDNA particles increased up
to a charge ratio of 9 (Fig. 1(a)). In contrast, the E(cyt) values
for the PLL/pDNA particles were independent of the charge
ratio. These results are in good agreement with the results of
a previous transfection study [20]. At a charge ratio of 2, it
is calculated that 1.3 lg of protamine or 0.83 lg of PLL are
used as a condensation per 1.0 lg pDNA. Under these condi-
tions, trans-gene expression after the lipofection of pre-
condensed particle by protamine was only slightly higher than
that by PLL [20]. When the charge ratio was increased, the
transfection activity for protamine-condensed pDNA was
drastically enhanced, whereas it was unaﬀected in the PLL-
condensed pDNA [20].
Since the protamine/pDNA particle appears to be trans-
ported to the nucleus in a condensed form, as shown in Fig.
2, intra-nuclear decondensation is necessary for achieving eﬃ-
cient transcription. In this sense, the E(cyt) values (Fig. 1(a))
should be aﬀected by intra-nuclear transcription as well as
nuclear transfer. To compare the nuclear transfer process, we
investigated the eﬃciency of intra-nuclear transcription by nu-
clear microinjection (E(nuc): Fig. 1(b)), and deﬁned the param-
eter, an NT score (Fig. 1(c)), which is denoted as E(cyt) divided
by E(nuc). It should be noted that the NTscore could be af-
fected by the decondensation eﬃciency of pDNA in the cyto-
plasm as well as nuclear transfer eﬃciency, since it may be
diﬀerent depending on the DNA condenser used [26]. How-
ever, when rhodamine-labeled pDNA, condensed with PLL
was injected into the cytoplasm, pDNA was also dominantly
observed as dot shaped forms, similar to protamine/pDNA
particles (Akita et al., unpublished observation), Therefore,
NTscores were used as an index of the nuclear transfer eﬃ-
ciency, based on the hypothesis that pDNA is mainly present
as the condensed form in the cytoplasm, whereas the extent
to which pDNA is actually released from polycations remains
unknown at this time. As a result, the NT score for protamine/pDNA particles signiﬁcantly increased depending on the
charge ratio, whereas it was unaﬀected in the case of PLL/
pDNA particles. Improved nuclear transfer was also con-
ﬁrmed by the quantiﬁcation of confocal images by a recently
developed CIDIQ method [25], in which the pixel areas of
the pDNA clusters are used as an index of the amount of
pDNA (Fig. 2). A proposed mechanism for the charge ratio-
dependent improvement of the nuclear transfer is shown in
Fig. 4. It is possible that the protamine molecule possess heter-
ogenic functions: one of which is a condenser of pDNA via its
arginine residues, and other of which is a nuclear localization
signal. At a low charge ratio, all of the basic amino acids of
protamine may be consumed in the condensation of pDNA,
and, as a result, the recognition of the nuclear localization sig-
nal by the nuclear transport-associating proteins (i.e., impor-
tins) would be limited. By increasing the charge ratio, the
protamine displayed on the surface of particles functions as
a nuclear localization signal, allowing the particles to be recog-
nized by nuclear transport-associating proteins.
However, this hypothesis is inconsistent with the generally
accepted theory that the maximum size of the macromolecules
for the passage of nuclear pore complex (NPC) is limited to up
to 39 nm as estimated by experiments using gold particles
[27]. Similarly, the nuclear transfer of pDNA as a condensed
form with a polycation (e.g., lactosylated PLL) was also re-
ported previously [28]. As opposed to the gold particle, a poly-
cation/pDNA particle may be ﬂexible in shape, and could
possibly pass through the limited size of the NPC by changing
its form. When the charge ratio was further increased from 9 to
12, the E(cyt) value decreased. Above a charge ratio of 9, free
protamine may inhibit the nuclear transfer of pDNA by com-
peting with the recognition of protamine/pDNA particles by
the nuclear transport-associating proteins, or the NPC-depen-
dent transfer process.
Unexpectedly, the NT score for protamine/pDNA particles
was not signiﬁcantly higher than that for PLL/pDNA particles.
This is not in agreement with the widely accepted opinion that
protamine is superior to PLL in delivering the pDNA into the
nucleus. Considering that the nuclear membrane consists of
the negative charged lipids such as cardiolipin, phosphatydyli-
nositol, phosphatidic acid and phosphatidylserine [29], posi-
tively charged particles should be eﬃciently drawn close to the
nucleus. Presumably, physicochemical characteristics, such as
high Z-potentials (Table 1) of PLL/pDNA particles are driving
forces for the nuclear delivery,which can complement the lack of
biologically active nuclear transport.
We also found that the E(nuc) values of protamine/pDNA
particles are signiﬁcantly higher than that of PLL/pDNA par-
ticles. Considering the previous report showing that arginine-
rich polycation condenses pDNA more tightly than a lysine-
rich one [30], it would be expected that arginine-rich protamine
would inhibit intra-nuclear transcription more severely than
PLL by interfering with the binding of transcriptional factors.
However, the result was completely diﬀerent and unexpected.
At fertilization, nucleoplasmin and related chaperone proteins
are responsible for the decondensation of the paternal genome
DNA from the protamine, leading to remodeling with histones
to form the diploid genome with maternal genomic DNA
[31,32]. Furthermore, in the remodeling, paternal genomic
DNA is eﬃciently remodeled with acetylated histones, and
rapidly demethylated for DNA activation [33]. Whereas mam-
malian orthologs of nucleoplasmin are exclusively expressed in
Fig. 4. Schematic diagram illustrating the possible mechanism for the improved nuclear transfer of pDNA by protamine. A possible mechanism for
the improved transfer of pDNA is illustrated. At a low charge ratio, the recognition of the nuclear localization signal by the nuclear transport-
associating proteins is limited since all of the basic amino acids (arginines) of protamine may be consumed in the condensation of pDNA. When the
charge ratio is increased, single protamine exhibits heterogenic functions: a partial domain involves in the pDNA condensation, and other domain is
displayed on the particle allowing them to be recognized as a nuclear localization signal.
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matic cells, including HeLa cells [35]. One such example in-
cludes the nuclear template-activating factor (TAF) family of
proteins, which play an important role in remodeling of the
adenovirus DNA/core protein complexes during adenovirus
infections [36]. Therefore, nuclear chaperone proteins may also
be involved in the remodeling of the protamine/pDNA com-
plex, allowing them to be subject to eﬀective transcription.
Alternatively, protamine may regulate the intra-nuclear local-
ization towards the nuclear matrix-rich regions, where it plays
an important role in gene translation [37,38].
Collectively, we succeeded in demonstrating the potential of
protamine to deliver pDNA to the nucleus in a charge ratio
dependent manner, as evidenced by a microinjection study.
Furthermore, we also found that pDNA, when condensed with
protamine, is more eﬃciently subject to transcription in the
nucleus than that condensed with PLL. Therefore, protamine
is an excellent pDNA condenser, which possesses bi-functional
advantages: improvement in nuclear targeting and eﬃcient in-
tra-nuclear transcription. This report provides the ﬁrst demon-
stration of the mechanism underlying the improved
transfection activity of pDNA, when condensed with prot-
amine, from the point of view of nuclear delivery and intra-nu-
clear transcription.Acknowledgements: This work was supported by grants from the
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